Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.57 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | HNF4A | P41235 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.41 |
| ▸ | PDE4A | P27815 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30288300 | 1.00 | CA2 (0.61) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL29065608 | 0.98 | CA2 (0.59) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL12503545 | 0.94 | CA2 (0.55) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL22472212 | 0.88 | HNF4A (0.48) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL12128896 | 0.88 | CA2 (0.61) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL29854235 | 0.86 | HNF4A (0.47) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL2210615 | 0.85 | CA2 (0.76) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL2917008 | 0.85 | CA2 (0.57) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL27743898 | 0.85 | CA2 (0.57) | CA2PTPN5GABRA1GABRB2NPSR1 | |
| SCHEMBL28026491 | 0.84 | CA2 (0.50) | CA2PTPN5GABRA1GABRB2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544069-B2 | Method for dimerization of ethylene comprising a step for treatment of the reaction effluent | IFP Energies Nouvelles (FR) | 2020-01-28 | — | — | US | claimed |
| CN-104941682-B | Catalyst composition and for making ethylene oligomerization at the method for 1- hexene | IFP 新能源公司 | 2019-07-30 | — | — | CN | claimed |
| CN-109942362-A | Include the steps that the ethylene dimerization method for handling reaction effluent | IFP 新能源公司 | 2019-06-28 | — | — | CN | claimed |
| US-20190169085-A1 | METHOD FOR DIMERIZATION OF ETHYLENE COMPRISING A STEP FOR TREATMENT OF THE REACTION EFFLUENT | IFP Energies Nouvelles (FR) | 2019-06-06 | — | — | US | claimed |
| US-9499455-B2 | Process for the selective dimerisation of ethylene to 1-butene | IFP Energies Nouvelles (FR) | 2016-11-22 | — | — | US | claimed |
| US-20150273456-A1 | NOVEL CATALYTIC COMPOSITION AND PROCESS FOR OLIGOMERIZING ETHYLENE INTO 1-HEXENE | IFP Energies Nouvelles (FR) | 2015-10-01 | — | — | US | claimed |
| US-6903042-B2 | Catalytic composition and process for oligomerizing ethylene, in particular to 1-hexene | INSTITUT FRANCAIS DU PETROLE (FR) | 2005-06-07 | — | — | US | claimed |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| US-12312312-B2 | Process for separating out an effluent obtained from an oligomerization step | IFP Energies Nouvelles (FR) | 2025-05-27 | — | — | US | disclosed |
| US-20240239725-A1 | METHOD FOR OLIGOMERISATION IN A REACTOR COMPRISING VARIABLE-DIAMETER ZONES, INCLUDING A STEP OF RECYCLING A PRE-COOLED SOLVENT | IFP Energies Nouvelles (FR) | 2024-07-18 | — | — | US | disclosed |
| EP-4347542-A1 | METHOD FOR OLIGOMERISATION IN A REACTOR COMPRISING VARIABLE-DIAMETER ZONES, INCLUDING A STEP OF RECYCLING A PRE-COOLED SOLVENT | IFP Energies nouvelles (FR) | 2024-04-10 | — | — | EP | disclosed |
| CN-117693496-A | Oligomerization process in a reactor having a variable diameter zone comprising a step of recycling pre-cooled solvent | IFP 新能源公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-112533889-B | Process for oligomerization in cascade with stirred gas-liquid reactor staged injection of ethylene | IFP 新能源公司 | 2024-03-05 | — | — | CN | disclosed |
| US-20010023281-A1 | Catalytic composition and a process for oligomerizing ethylene, in particular to 1-hexene | INSTITUT FRANCAIS DU PETROLE (FR) | 2001-09-20 | — | — | US | disclosed |
| EP-1110930-A1 | Catalytic composition and process for the oligomerisation of ethylene, to primarily 1-hexene | INSTITUT FRANCAIS DU PETROLE (FR) | 2001-06-27 | — | — | EP | disclosed |
| EP-0591010-B1 | Organic photosensitive material for electrophotography | MITA INDUSTRIAL CO LTD (JP) | 1997-08-20 | — | — | EP | disclosed |
| US-5449580-A | Organic photosensitive material for electrophotography | MITA INDUSTRIAL CO., LTD. (JP) | 1995-09-12 | — | — | US | disclosed |
| EP-0591010-A1 | Organic photosensitive material for electrophotography | MITA INDUSTRIAL CO., LTD. (JP) | 1994-04-06 | — | — | EP | disclosed |
| US-4061617-A | ANTIOXIDANT, DIELECTRIC STABILIZERS, SEMICONDUCTORS, ION EXCHANGE RESINS | GENERAL ELECTRIC COMPANY (US) | 1977-12-06 | — | — | US | disclosed |
| US-3959223-A | Oxidation-reduction diphenoquinone-diphenonhydroquinone polymers | GENERAL ELECTRIC COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239725-A1 | METHOD FOR OLIGOMERISATION IN A REACTOR COMPRISING VARIABLE-DIAMETER ZONES, INCLUDING A STEP OF RECYCLING A PRE-COOLED SOLVENT | PRPF40A, NSF, NOD2 | CA2 1843/4885PTPN5 4275/4885GABRA1 2348/4885 |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | PFAS, PHOSPHO1, PAF1 | CA2 2802/4885PTPN5 2208/4885GABRA1 2733/4885 |
| US-20150273456-A1 | NOVEL CATALYTIC COMPOSITION AND PROCESS FOR OLIGOMERIZING ETHYLENE INTO 1-HEXENE | XRN2, XDH, SOD1 | CA2 14/4885PTPN5 2325/4885GABRA1 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.